OTCMKTS:SNWV SANUWAVE Health (SNWV) Stock Price, News & Analysis → Gold Set to EXPLODE! (From Gold Safe Exchange) (Ad) Free SNWV Stock Alerts $0.02 0.00 (0.00%) (As of 05/14/2024 ET) Add Compare Share Share Today's Range$0.02▼$0.0250-Day Range$0.02▼$0.0252-Week Range$0.00▼$0.03Volume1.08 million shsAverage Volume412,794 shsMarket Capitalization$22.70 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Get SANUWAVE Health alerts: Email Address Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… About SANUWAVE Health Stock (OTCMKTS:SNWV)SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's pulsed acoustic cellular expression systems, including dermaPACE system for treating diabetic foot ulcers and other chronic wounds; orthoPACE system for treating tendinopathies and acute and nonunion fractures; and Profile is used to provide therapeutic treatment of musculoskeletal conditions. Its portfolio of wound treatment solutions provides patients with a noninvasive technology that boosts the body's normal healing and tissue regeneration processes. In addition, the company offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds. SANUWAVE Health, Inc. was founded in 2004 and is headquartered in Eden Prairie, Minnesota.Read More SNWV Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SNWV Stock News HeadlinesMay 13 at 11:38 AM | investorplace.comSNWV Stock Earnings: SANUWAVE Health Reported Results for Q1 2024May 13 at 7:22 AM | finance.yahoo.comSANUWAVE Health Inc (SNWV) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth ...May 13 at 4:50 AM | americanbankingnews.comSANUWAVE Health, Inc. (OTCMKTS:SNWV) Sees Significant Increase in Short InterestMay 12 at 12:19 AM | uk.finance.yahoo.comQ1 2024 SANUWAVE Health Inc Earnings CallMay 10, 2024 | finance.yahoo.comSANUWAVE Announces Q1 FY2024 Financial ResultsMay 7, 2024 | finance.yahoo.comSANUWAVE Will Host a Conference Call on May 10, 2024 at 8:30 AM (ET) to Present Q1 Financial ResultsApril 10, 2024 | globenewswire.comSANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2024 (Ended March 31, 2024)April 1, 2024 | globenewswire.comSANUWAVE Health Appoints Industry Veteran Peter Sorensen as Chief Financial OfficerMarch 25, 2024 | msn.comSANUWAVE Health, Inc. (PNK:SNWV) Q4 2023 Earnings Call TranscriptMarch 22, 2024 | globenewswire.comSANUWAVE Announces Record Q4 and FY2023 RevenueMarch 20, 2024 | globenewswire.comSANUWAVE Will Host a Conference Call on March 22, 2024 at 8:30 AM (ET) to Present the Q4 and FY2023 Financial ResultsFebruary 23, 2024 | finanznachrichten.deSANUWAVE Health, Inc.: SANUWAVE Health Reports Stockholder Approval of SEPA Merger at Special Meeting of StockholdersFebruary 23, 2024 | benzinga.comSANUWAVE Health Stock (OTC:SNWV) Dividends: History, Yield and DatesFebruary 22, 2024 | globenewswire.comSANUWAVE Health Reports Stockholder Approval of SEPA Merger at Special Meeting of StockholdersFebruary 1, 2024 | msn.comSEP Acquisition shareholders approve Sanuwave SPAC mergerJanuary 26, 2024 | msn.comSanuwave Health Announces New Financial Obligation RegistrationJanuary 22, 2024 | markets.businessinsider.comEQS-News: SANUWAVE Announces Special Meeting of Stockholders to Vote on Business Combination with SEP Acquisition Corp. (Nasdaq: SEPA)January 22, 2024 | finance.yahoo.comSANUWAVE Announces Special Meeting of Stockholders to Vote on Business Combination with SEP Acquisition Corp. (Nasdaq: SEPA)January 10, 2024 | msn.comSanuwave Health sees Q4 record revenue $6.6M-$6.8M, up 20% Y/YJanuary 10, 2024 | finance.yahoo.comSANUWAVE Health Announces Preliminary Revenue Results for the Fourth Quarter and Fiscal Year 2023, Ended December 31, 2023November 11, 2023 | finanznachrichten.deSANUWAVE Health, Inc.: SANUWAVE Announces Q3 2023 Financial ResultsNovember 10, 2023 | msn.comSANUWAVE Health GAAP EPS of -$0.03, revenue of $5M; initiates Q4 outlookNovember 8, 2023 | finance.yahoo.comSANUWAVE Will Host a Conference Call on November 10, 2023 at 8:00 AM (ET) to Present the Q3 2023 Financial ResultsOctober 10, 2023 | finance.yahoo.comSANUWAVE Health Announces Preliminary Revenue Results for the Third Quarter Ended September 30, 2023August 23, 2023 | msn.comSanuwave Health eyes Nasdaq listing, announces merger with SEP AcquisitionSee More Headlines Receive SNWV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SANUWAVE Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/21/2024Today5/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolOTCMKTS:SNWV CUSIPN/A CIK1417663 Webwww.sanuwave.com Phone(770) 419-7525Fax770-419-8634Employees31Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-25,810,000.00 Net Margins-77.00% Pretax Margin-76.99% Return on Equity-3.81% Return on Assets9.71% Debt Debt-to-Equity RatioN/A Current Ratio0.15 Quick Ratio0.12 Sales & Book Value Annual Sales$20.40 million Price / Sales1.11 Cash FlowN/A Price / Cash FlowN/A Book Value($0.04) per share Price / Book-0.50Miscellaneous Outstanding Shares1,140,560,000Free Float953,507,000Market Cap$22.70 million OptionableNot Optionable Beta1.06 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesMr. Morgan C. Frank (Age 51)CEO & Chairman Comp: $200kMr. Kevin A. Richardson II (Age 56)Chief Strategy Officer & Director Comp: $470kMr. Timothy Hendricks (Age 49)Executive VP of Sales for U.S. Wound Business Comp: $323.46kMr. Andrew Walko (Age 39)President Mr. Peter SorensenChief Financial OfficerMr. Peter Stegagno (Age 64)Chief Operating Officer Comp: $247.83kDr. Iulian Cioanta Ph.D. (Age 61)Chief Science & Technology Officer Comp: $233.68kMore ExecutivesKey CompetitorsT2 BiosystemsNASDAQ:TTOOPolyPidNASDAQ:PYPDLyra TherapeuticsNASDAQ:LYRANephrosNASDAQ:NEPHPAVmedNASDAQ:PAVMView All Competitors SNWV Stock Analysis - Frequently Asked Questions How have SNWV shares performed in 2024? SANUWAVE Health's stock was trading at $0.0130 at the beginning of the year. Since then, SNWV shares have increased by 53.1% and is now trading at $0.0199. View the best growth stocks for 2024 here. Are investors shorting SANUWAVE Health? SANUWAVE Health saw a increase in short interest in April. As of April 30th, there was short interest totaling 121,000 shares, an increase of 18.5% from the April 15th total of 102,100 shares. Based on an average trading volume of 509,800 shares, the days-to-cover ratio is presently 0.2 days. View SANUWAVE Health's Short Interest. How were SANUWAVE Health's earnings last quarter? SANUWAVE Health, Inc. (OTCMKTS:SNWV) released its earnings results on Thursday, March, 21st. The company reported $0.03 earnings per share (EPS) for the quarter. The firm had revenue of $6.99 million for the quarter. SANUWAVE Health had a negative trailing twelve-month return on equity of 3.81% and a negative net margin of 77.00%. What guidance has SANUWAVE Health issued on next quarter's earnings? SANUWAVE Health issued an update on its second quarter 2024 earnings guidance on Friday, May, 10th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $6.8 million-$7.2 million. What other stocks do shareholders of SANUWAVE Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other SANUWAVE Health investors own include Co-Diagnostics (CODX), iBio (IBIO), Sierra Oncology (SRRA), Tonix Pharmaceuticals (TNXP), Digital Ally (DGLY), Kopin (KOPN), T2 Biosystems (TTOO) and VBI Vaccines (VBIV). How do I buy shares of SANUWAVE Health? Shares of SNWV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:SNWV) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadBanyan Hill PublishingWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersBill Clinton Backing Biden Replacement???The Freeport SocietyGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SANUWAVE Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
